New prospects of mesenchymal stem cells for ameliorating temporal lobe epilepsy

NA Salem, M El-Shamarka, Y Khadrawy… - …, 2018 - Springer
Temporal lobe epilepsy (TLE) is present in 30% of epileptic patients and does not respond
to conventional treatments. Bone marrow derived mesenchymal stem cells (BMSCs) induce …

New prospects of mesenchymal stem cells for ameliorating temporal lobe epilepsy

NA Salem, M El-Shamarka… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Temporal lobe epilepsy (TLE) is present in 30% of epileptic patients and does not respond
to conventional treatments. Bone marrow derived mesenchymal stem cells (BMSCs) induce …

[PDF][PDF] New prospects of mesenchymal stem cells for ameliorating temporal lobe epilepsy

NA Salem, M El‑Shamarka, Y Khadrawy… - 2018 - academia.edu
Temporal lobe epilepsy (TLE) is present in 30% of epileptic patients and does not respond
to conventional treatments. Bone marrow derived mesenchymal stem cells (BMSCs) induce …

New prospects of mesenchymal stem cells for ameliorating temporal lobe epilepsy.

NA Salem, M El-Shamarka, Y Khadrawy… - …, 2018 - europepmc.org
Temporal lobe epilepsy (TLE) is present in 30% of epileptic patients and does not respond
to conventional treatments. Bone marrow derived mesenchymal stem cells (BMSCs) induce …